|
Scleroderma, Localized
|
C17.300.787 |
|
|
Osteoarthritis, Spine
|
C05.550.114.865.399 |
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
C04.700.517 |
|
|
Adrenocortical Adenoma
|
C19.053.347.500.500 |
|
|
Adrenal Cortex Neoplasms
|
C19.053.347.500 |
|
|
rac1 GTP-Binding Protein
|
D08.811.277.040.330.300.400.700.100.500 |
|
|
rac GTP-Binding Proteins
|
D08.811.277.040.330.300.400.700.100 |
|
|
Anthocyanins
|
D03.383.663.283.266.450.087 |
|
|
Immunosuppressive Agents
|
D27.505.696.477.656 |
|
|
Immunologic Factors
|
D27.505.696.477 |
|
|
TATA Box
|
G05.360.080.689.675.850 |
|
|
Congenital Hypothyroidism
|
C16.320.240.625 |
|
|
Dwarfism
|
C16.320.240 |
|
|
Rilpivirine
|
D000068696 |
[A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone.
] |
|
Tumor Suppressor Protein p14ARF
|
D12.776.167.600 |
|
|
Cell Cycle Proteins
|
D12.776.167 |
|
|
Tenofovir
|
D000068698 |
[An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.
] |
|
Gnetum
|
B01.650.940.800.575.156.577.333 |
|
|
Domestic Violence
|
I01.198.240.856.350 |
|
|
Scientific Experimental Error
|
E05.318.370.725.250.500 |
|
